BJ

Bhanudas Jaggannath Mohite

Active Director Director DIN 00098798
DIN 00098798 First appointment Dec 2001 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 3 historical roles
Total affiliations 5 Since Dec 2001
Shareholding value •••• Premium profile

About Bhanudas Jaggannath Mohite

Data last updated:

Bhanudas Jaggannath Mohite is a Director at Priyadarshini Microtech Private Limited (since 2001) and Director at Alchemy Laboratories Private Limited (since 2017). The companies operate in Pharma, Chemicals and Travel and Hospitality. The 2 current companies with reported revenue have a combined latest revenue of ₹10.07 Cr; the largest is Priyadarshini Microtech Private Limited at ₹8.71 Cr (FY 2025). Earlier, Bhanudas Jaggannath Mohite was a Director at Creative Diagnostic Medicare Private Limited (2003–2010) and Director at Solasta Laboratories Private Limited (2018–2021) and 1 more.

DIN 00098798
Primary Designation Director
Industry Pharma
First Appointment 21 Dec 2001
Oldest Company Age 24 yrs
Largest company Priyadarshini Microtech Private Limited · ₹8.71 Cr (FY 2025)
Combined revenue ₹10.07 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Dec 20012001₹8.71 Cr (FY 2025)Active
Alchemy Laboratories Private Limited U24233MH2010PTC206952
Director13 Jan 20172010₹1.36 Cr (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director11 Jun 20032003₹6.73 Cr (FY 2025)Active
Solasta Laboratories Private Limited U74999MH2018PTC304867
Director06 Feb 20182018Active
Director30 Jun 20162016Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Alchemy Laboratories Private Limited
Priyadarshini Microtech Private Limited
Creative Diagnostic Medicare Private Limited
Solasta Laboratories Private Limited
Premium access

Shareholding and investment profile for Bhanudas Jaggannath Mohite

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhanudas Jaggannath Mohite

Bhanudas Jaggannath Mohite currently holds 2 directorships: Priyadarshini Microtech Private Limited (Director, since 21 Dec 2001, revenue ₹8.71 Cr (FY 2025)); Alchemy Laboratories Private Limited (Director, since 13 Jan 2017, revenue ₹1.36 Cr (FY 2024)).

Bhanudas Jaggannath Mohite was first appointed on 21 Dec 2001 as Director at Priyadarshini Microtech Private Limited. The most recent appointment on record is 06 Feb 2018 at Solasta Laboratories Private Limited.

The 2 current companies of Bhanudas Jaggannath Mohite that report revenue have a combined latest revenue of ₹10.07 Cr: Priyadarshini Microtech Private Limited ₹8.71 Cr (FY 2025); Alchemy Laboratories Private Limited ₹1.36 Cr (FY 2024).

Bhanudas Jaggannath Mohite held 3 earlier board appointments: Creative Diagnostic Medicare Private Limited (Director, 11 Jun 2003 to 01 Dec 2010); Solasta Laboratories Private Limited (Director, 06 Feb 2018 to 30 Apr 2021); Shivshakti Eco Tech Ventures Private Limited (Director, 30 Jun 2016 to 14 Jun 2019).

The current boards of Bhanudas Jaggannath Mohite's companies include Jaymala Bhanudas Mohite (Priyadarshini Microtech Private Limited), Priyadarshini Bhanudas Mohite (Priyadarshini Microtech Private Limited), Pranay Ramkrishna Nikam (Alchemy Laboratories Private Limited), Ramkrishna Marthandrao Nikam (Alchemy Laboratories Private Limited), Sunit Balkrishna Padgaonkar (Alchemy Laboratories Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available